Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Domvanalimab's trials
EDGE-Lung
Study With Various Immunotherapy Treatments in Participants With Lung Cancer
Domvanalimab
Ongoing
Active not recruiting
Phase 2
Open NCT05676931 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record
EDGE-Lung · Trial Tracker · ComplyRx
